Stock Events

Stock Events

ChronoScale

$22.35

55

+$1.41+6.76% 18:46 Today

Statistics

Day High

22.39

Day Low

20.64

52W High

30

52W Low

3.01

Volume

51,726

Avg. Volume

334,291

Mkt Cap

3.24B

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

17AugExpected

Q3 2025

Q1 2026

Next

-0.97

-0.65

-0.34

-0.03

Expected EPS

-0.0626

Actual EPS

N/A

Financials

-91.37%Profit Margin

Unprofitable

2020

2021

2022

2023

2024

2025

12.8MRevenue

-11.7MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ResMed Inc. competes in the development, manufacturing, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, including sleep apnea, a field closely related to Ekso Bionics' focus on medical devices for physical assistance.

Community Health Systems

Community Health Systems, Inc. operates hospitals and healthcare facilities, which could be potential users of Ekso Bionics' medical devices, making them indirect competitors in the healthcare solutions market.

Zimmer Biomet Holdings, Inc. manufactures and markets orthopedic reconstructive products, competing with Ekso Bionics in the broader market for medical devices that aid mobility.

Smith & Nephew plc designs, manufactures, and markets medical devices for the orthopedic market, competing with Ekso Bionics in the development of technologies for physical rehabilitation.

Medtronic plc specializes in medical technologies, services, and solutions, including those for spinal and musculoskeletal conditions, making it a competitor in the medical device market alongside Ekso Bionics.

Stryker Corporation specializes in medical technologies, including orthopedics, making it a competitor in the market for devices that support physical mobility and rehabilitation.

Globus Medical, Inc. focuses on musculoskeletal solutions, directly competing with Ekso Bionics in the development and marketing of medical devices aimed at improving physical mobility.

Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing indirectly with Ekson Bionics by offering alternative solutions for patient care.

About

ChronoScale Holdings Corp is being formed to become an accelerated compute platform purpose-built to support the demanding artificial intelligence workloads. To be formed through the strategic business combination of Applied Digital Cloud and EKSO, ChronoScale is expected to deliver scalable GPU-based infrastructure optimized for AI training, inference, and high-performance computing, leveraging an operating foundation designed for performance, reliability, and rapid deployment.

Show more...

CEO

Ying Cenly Chen

Employees

61

Country

United States

ISIN

US1709241046

WKN

000A427JC

Listings

0 Comments

Share your thoughts

FAQ

What is ChronoScale stock price today?▼

The current price of CHRN is $22.35 USD — it has increased by +6.76% in the past 24 hours. Watch ChronoScale stock price performance more closely on the chart.

What is ChronoScale stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ChronoScale stocks are traded under the ticker CHRN.

What is ChronoScale market cap?▼

Today ChronoScale has the market capitalization of 3.24B

What is ChronoScale revenue for the last year?▼

ChronoScale revenue for the last year amounts to 12.8M USD.

What is ChronoScale net income for the last year?▼

CHRN net income for the last year is -11.7M USD.

How many employees does ChronoScale have?▼

As of August 17, 2026, the company has 61 employees.

In which sector is ChronoScale located?▼

ChronoScale operates in the Technology sector.

When did ChronoScale complete a stock split?▼

The last stock split for ChronoScale was on June 02, 2025 with a ratio of 1:15.

Where is ChronoScale headquartered?▼

ChronoScale is headquartered in SAN RAFAEL, United States.